Our Team

Lonnie Bookbinder, MBA, PhD

CEO, Board Chairman

Leadership in pharma industry, drug licensing to pharma, serial entrepreneur, 47 years in industry

Glenn Kazo

Board Member

President Prolong Pharma, raised $300M, 3 IPOs, and Inventor of PEGylation.

Mark Kester, PhD

Board Member

Director of Nanotech Center & Pharmacology Professor at U. VA, Drug Delivery Systems; co-founder Keystone Nano

Narendra Vaish, PhD

Chief Scientific Officer, Board Member

Expert in RNA Inhibition and siRNA drug design with >100 biomed patents– also our patent agent.

Brad Niles, PhD

Chief Operating Officer, VP R&D

Managed Oncology Labs at UCD/Industry, expert in drug discovery, in-vitro assays, and IP

Gary Hooper, MBA

Chief Business Officer, VP Corporate Development

Ex Pharma/Genentech, CEO Multiple biotech firms, expertise in licensing to pharmaceutical companies

Kari Rundquist

Chief Financial Officer & VP of Communications

Honor Degree: Finance, expertise in fundraising, entrepreneurship, investor relations, & communications

Nicole Nuñez, PhD

Research Scientist

Expert in cancer molecular biology, + medicinal chem.

Contact Us